Related Experiment Videos
Ferrochelatase structural mutant (Fechm1Pas) in the house mouse
S Boulechfar1, J Lamoril, X Montagutelli
1Laboratoire de Génétique Moléculaire, Faculté X. Bichat, Université Paris 7, France.
Genomics
|June 1, 1993
Summary
Researchers identified a specific genetic mutation (M98K) causing ferrochelatase deficiency in a mouse model. This mouse offers a valuable tool for studying human porphyria and developing gene therapies.
Area of Science:
- Biochemistry
- Genetics
- Animal Models
Background:
- Inherited defects in ferrochelatase cause human disease.
- A specific mouse model (Fechm1Pas/Fechm1Pas) exhibits ferrochelatase deficiency.
Purpose of the Study:
- To investigate the molecular basis of the inherited ferrochelatase defect in the Fechm1Pas/Fechm1Pas mouse.
- To characterize the mutation and its functional consequences.
Main Methods:
- Isolation and sequencing of ferrochelatase cDNA from mutant mouse liver using PCR.
- Dideoxynucleotide chain-termination sequencing.
- Allele-specific oligonucleotide (ASO) hybridization for mutation confirmation.
- Expression of mutant ferrochelatase in E. coli.
Main Results:
- A T to A transversion at nucleotide 293 was identified, resulting in a methionine to lysine substitution (M98K) at position 98.
- The mutation was confirmed at both cDNA and genomic levels.
- Mutant ferrochelatase expressed in E. coli showed significantly reduced enzymatic activity.
Conclusions:
- The Fechm1Pas/Fechm1Pas mouse model harbors a specific molecular defect (M98K mutation) leading to ferrochelatase deficiency.
- This mouse model is valuable for studying porphyria pathophysiology and exploring gene therapy strategies.